Sunday, March 17, 2013

The Supreme Court, preemption and generic drug manufacturers

This week the US Supreme Court will hear oral arguments in a case called Mutual Pharmaceutical v. Bartlett which asks the Court to decide whether a generic drug maker can be held liable for a design defect. See here and here.  In anticipation of this very important case, a number of blogs have published posts on the issues.  Here are three good ones:  Preemption again (SCOTUS blog), Argument Preview (SCOTUS blog), Supreme Court to Hear Generic Drug Suit (Politico).

No comments: